An interaction between HDAC inhibitors and the multi-kinase inhibitor pazopanib, both in vitro and in vivo, has been recently evidenced to induce apoptosis in sarcoma cells and decrease tumor growth (175–177). This evidence concerns the gene HDAC9 and neoplasm.